Mr. Pandolfino founded 22nd Century Limited, LLC in 1998 and has over 15 years experience in all aspects of the tobacco industry, including 12 years with genetically-engineered tobacco. The first genetically-engineered tobacco variety deregulated by APHIS (Animal and Plant Health Inspection Service) of the USDA resulted from our sponsored research agreement with a major university which Mr. Pandolfino initiated and managed. Cigarettes containing this globally-patented very low nicotine tobacco have been commercialized and used in many studies, including various phase II smoking-cessation clinical trials. Mr. Pandolfino oversees our operations, strategy and product development. He holds a Bachelor of Science Degree in Business Administration from Medaille College and a Master of Business Administration Degree from the State University of New York at Buffalo.


Henry Sicignano, III, MBA, President

Mr. Sicignano has joined us as our President in 2010. From 2005 to 2009, Mr. Sicignano served as a General Manager and as the Director of Corporate Marketing for NOCO Energy Corp., a petroleum products company; and from 2003 to 2005, as Vice President of Kittinger Furniture Company, Inc., a fine furniture manufacturer. From 1997 through 2002, he served as Vice President and Marketing Director of Santa Fe Natural Tobacco, a specialty tobacco company, prior to the sale of that company to R.J. Reynolds Tobacco Company in 2002. Mr. Sicignano holds a Bachelors of Arts Degree in Government and a Master of Business Administration Degree from Harvard University.


Michael R. Moynihan, Ph.D., Vice President of R&D

Dr. Moynihan has served as our Vice President of R&D since 2007 and as a consultant for us since 1999. From 2001 to 2006 he served as Director of Biotechnology Development at Fundación Chile and from 1995 to 2000 as Senior Project Director at InterLink Biotechnologies LLC. He previously served as a Visiting Research Fellow at the Institute for Molecular and Cellular Biology, Osaka University, Japan; a Postdoctoral Associate in the Section of Plant Biology, Cornell University; and a Postdoctoral Associate at the Center for Agricultural Molecular Biology, Rutgers University. Dr. Moynihan holds a Bachelor of Science Degree in Biology from Brown University and a Master’s Degree and Ph.D. in Biology from Harvard University.


C. Anthony Rider, CPA, Chief Financial Officer

Mr. Rider has been a member and has served as our Chief Financial Officer on a part-time basis since 2007. He has also served since 2007 as Chief Financial Officer of Locke Acquisition Group LLC, which is unrelated to us. Mr. Rider served as the Chief Financial Officer of Astronics Corporation, a public company, from 2000 to 2005, and as the Chief Financial Officer of IIMAK, a private-equity sponsored international manufacturing company, from 2005 to 2007. He is a member of the AICPA and the New York State Society of CPAs. From 1973 to 2000, Mr. Rider was employed by Ernst & Young, where he specialized in working with entrepreneurial growth companies, and was the partner responsible for developing and administering Ernst & Young’s entrepreneurial services practice for Upstate New York and Western Pennsylvania. Mr. Rider holds a Bachelor of Science Degree from Canisius College.